DJIA 18,232.02 0.00 0.00%
NASDAQ 5,089.36 0.00 0.00%
S&P 500 2,126.06 0.00 0.00%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.68 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.68 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.65
Previous Close $0.68
Daily Range $0.63 - $0.68
52-Week Range $0.54 - $2.43
Market Cap $71.3M
P/E Ratio -1.31
Dividend (Yield) $0.00 (0.0%)
Volume 12,000,152
Average Daily Volume 2,783,075
Current FY EPS -$0.42

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

StemCells (STEM) Q1 2015 Results - Earnings Call Webcast

Dissecting StemCells Latest Capital Raise

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

Health Care Sector Update for 03/17/2015: STEM,ESPR,CNAT

Benzinga's Top #PreMarket Losers

StemCells' (STEM) CEO Martin McGlynn Discusses on Q4 2014 Results - Earnings Call Transcript

See More STEM News...

STEM's Top Competitors

STEM $0.68 (0.00%)
Current stock: STEM
GILD $111.71 (0.00%)
Current stock: GILD
AMGN $163.58 (0.00%)
Current stock: AMGN
BIIB $398.68 (0.00%)
Current stock: BIIB